Back to catalogue
№ 032 18 filings · 2021-10-29 → 2025-11-27

ARROW EXPLORATION CORP.

AXL
Energy Market cap £80m Overall fit 130 /1000

Pure oil & gas E&P with zero AI-receiver exposure and only modest commodity operating leverage; doesn't fit the strategy regardless of how cheap it may be relative to NAV.

Fair value range 35p–75p Mid case · £155m
Absolute upside +93.6% vs current market cap
Conviction 2/5 confidence in undervalued call
Supports the call
  • YE2023 2P NPV10 of US$280m provides credible NAV anchor materially above current mcap
  • Net cash balance sheet with undrawn US$20m prepayment facility — no near-term solvency risk
Limits the call
  • Tapir block extension is unresolved — binary regulatory outcome on the asset that contains essentially the entire company
  • 2025 water-cut and opex deterioration makes the YE2023 reserve NAV stale; no updated reserves filing in the dataset
Methodology

NAV based on YE2023 2P NPV10 with haircuts for 2025 netback/opex deterioration and Tapir extension risk

In one line · bull case

Net-cash Colombian oil junior trading at roughly one-fifth of its disclosed 2P NPV10, with multiple near-term Tapir-block drilling catalysts.

In one line · biggest risk

The Tapir block extension is unresolved and essentially the entire company sits on that contract.

Drivers
AI beneficiary 5 /100
Traditional oil & gas explorer; no AI angle, no AI-driven revenue or addressable market.
Operating leverage 35 /100
Commodity-price leveraged but recent quarters show negative volume leverage as water cuts inflated per-boe opex.
Earnings vs expectations 40 /100
Material beats vs trajectory 2022–24; clear miss vs prior pace in 2025 on production and netbacks.
Growth momentum 40 /100
FY production roughly flat 2024→2025 despite heavy capex; momentum has clearly cooled from the 2022–24 ramp.
Moat 15 /100
None — small price-taking E&P competing for permits, rigs, and reserves on commodity terms.
Earnings quality 60 /100
IFRS, audited annuals clean; some inherent estimation in reserves-based depletion and impairment but no aggressive flags.
Management quality 50 /100
Strong RCE/CN execution 2022–24; Mateguafa drilling progress in 2025; but Tapir extension delay and 2025 water-handling slip warrant pause.
Cyclicality 88 /100
Deeply cyclical Brent-linked oil producer with country-specific Colombian fiscal/political exposure.
Leverage 10 /100
Net cash, no drawn debt, plus undrawn US$20m prepayment facility — fortress for a junior of this size.
Value-trap signals · 4
  • Production flat YoY despite ~$35m YTD-25 capex
  • Per-boe opex roughly doubled YoY in 2025 with promised water-handling fixes still in progress
  • On-demand loans to executives/directors (~$0.7m) sit in other receivables
  • Tapir block extension unresolved — existential single point of failure

ARROW EXPLORATION CORP. (AXL) — Research Note

Executive summary

Arrow Exploration is an AIM-listed Canadian junior with all its current production from Colombia — primarily the Tapir block in the Llanos basin (Rio Cravo Este, Carrizales Norte, Alberta Llanos) plus the smaller Oso Pardo and dormant Ombu blocks, with a tail of Alberta gas. Operationally the period covered shows a sharp ramp from 461 boe/d in FY2021 to a Q4-2024 peak of 4,738 boe/d, then a step back to 4,023 boe/d YTD 2025 as water cuts rose, netbacks fell from $50.76/boe (Q3-24) to $35.72/boe (Q3-25), and the company spent heavily ($35.4m YTD-25 capex) without growing production. The single most important valuation question is whether the Tapir block extension is granted — without it, the asset that contains essentially all of Arrow's reserves and production goes away.

Fair value estimate

Methodology: NAV anchored to the company's YE2023 reserve report (last filed in dataset), with haircuts for the 2025 deterioration in netbacks and the unresolved Tapir extension.

  • YE2023 2P NPV10 pre-tax: US$280m (≈£218m at ~0.78 GBP/USD)
  • YE2023 1P NPV10 pre-tax: US$135m (≈£105m)
  • 2025 reality check: realized corporate price down ~16% YTD, opex per boe roughly doubled, capex outpacing production growth. A 25–35% haircut to the 2P NAV is defensible.

Fair value range (per share, pence):

  • Low: ~35p (1P NAV-equivalent, heavy haircut for Tapir/cost risk) → mcap ~£100m
  • High: ~75p (2P NAV near full credit, assumes Tapir extension granted, opex normalises) → mcap ~£215m
  • Mid: ~55p / £155m mcap

Compared to current £62.9m mcap (~22p): absolute upside ~150% to the midpoint, ~60% to the low. The asset base appears materially undervalued if the Tapir extension is granted and Mateguafa Attic / Icaco deliver — both are open questions, which is why I do not anchor at the optimistic end.

Sector context

Confirmed: ICB Energy, oil & gas E&P, small-cap Latin-America-focused junior. Quality is below the average AIM oil-junior peer set on production size, but balance sheet is well above average (no debt, net cash). Closest listed peers:

  • GeoPark (NYSE: GPRK) — far larger Colombian focus
  • Gran Tierra Energy (TSX/NYSE: GTE) — Colombia/Ecuador mid-cap
  • Petrolia Energy / Trillion Energy / Jadestone — small-cap E&P comparators on AIM/TSX-V

Investment thesis

  • Producing asset base trades at a steep discount to 2P NAV. YE2023 2P NPV10 pre-tax of US$280m vs current £63m mcap is a >3× gap; even with conservative haircuts the equity looks cheap if Colombia execution continues 2024-04 annual results, 2024-12 reserves filing.
  • Fortress balance sheet for a junior. Net cash position, no drawn debt at Q3-25, plus undrawn US$20m crude prepayment facility with an integrated major — meaning the 2026 Icaco exploration well, Mateguafa Attic development, and ongoing Tapir program can be self-funded from cash flow 2025-11 Q3-25 results.
  • Multiple near-term catalysts. Mateguafa Attic discovery being delineated (M-5, M-6, M-HZ7), Icaco prospect to be drilled Q1 2026, and Tapir extension decision pending — any positive outcome could re-rate the equity materially 2025-11 Q3-25 results.

Key risks

  • Tapir block extension is unresolved and existential. Tapir is essentially the whole company — RCE, CN, Alberta Llanos, Mateguafa, and Icaco all sit on it. Management says "all requirements met," but the Colombian regulator has not signed; if denied or materially restructured, fair value collapses 2025-11 Q3-25 results.
  • Water cut and opex deterioration in 2025. Crude opex jumped from $5.91/bbl in Q3-24 to $11.88/bbl in Q3-25 as wells produced more water; corporate netback halved YoY. If water management investments don't pay back as guided, netbacks stay compressed 2025-11 Q3-25 results, 2025-08 Q2-25 results.
  • Commodity & country risk. Brent has slid to ~$70 from $80-plus, Colombian fiscal regime is politically volatile (royalty deductibility ruling, presidential rhetoric on hydrocarbons), and the company has $12m of work commitments on the COR-39 block it is trying to cancel (not disclosed but inferred — failure to cancel would crystallise cash outflow).

Operating leverage

Arrow has modest, not strong, operating leverage. Fixed cost base is dominated by G&A (~$10m run-rate, broadly flat) and central depletion; variable costs are royalties (~12% of revenue) plus production opex which has actually been negatively operating-leveraged in 2025 (more wells = more water = higher per-boe lifting cost). Incremental revenue from a new horizontal well at CN or RCE drops at roughly netback economics — recently $35/boe, historically $50/boe. So a 10–20% revenue surprise (say from a successful Mateguafa Attic / Icaco discovery) would plausibly add ~30–50% to operating profit, not multiples. This is commodity-producer operating leverage — meaningful but not the asymmetric long-tail the investor profile is seeking 2025-11 Q3-25 results, segmented data.

Value-trap signals

  • Production stagnation despite heavy capex. $35m spent YTD 2025 has held production roughly flat YoY — the capital intensity is materially higher than the 2024 program implied.
  • Operating cost deterioration unaddressed for multiple quarters. Water-handling problems have run from Q1 through Q3 2025 with promised infrastructure fixes still in progress.
  • Related-party loans to executives and directors of ~$0.7m outstanding at Q3-25 (note 4, trade and other receivables) — small but a governance flag.
  • Tapir extension delay is genuinely a structural threat, not a temporary mispricing — if it goes wrong, the discount to NAV is justified.

Earnings vs. expectations

Arrow does not issue formal numerical guidance and is not covered by sell-side consensus in the conventional sense. Comparing reported delivery against management's own indications: 2022–2024 trajectory beat management's prior expectations — production grew from 461 boe/d (FY21) to 1,345 (FY22) to 2,167 (FY23) to 3,542 (FY24), well ahead of any prior pacing. 2025 has materially undershot. Q1-25 production was 14% below Q4-24, water issues escalated through Q2, capex ran ahead of plan, and Q3-25 netback was $35.72/boe vs management's own $50+ baseline. Pattern: strong beats 2022–24, clear miss vs trajectory in 2025.

Conviction

Conviction: 2 (low)

Anchors: (i) the reserve report and netback economics give a credible NAV floor, (ii) the balance sheet is unambiguous (net cash, no debt) so the company is not at financial risk in the next 12 months. Limiters: (i) the Tapir extension is binary and unresolved — a single regulatory event can move fair value 50%+ in either direction, (ii) the 2025 operational deterioration (water cuts, opex inflation) makes the YE2023 reserves report stale, and I do not have a 2025 reserves update in the filings provided, (iii) commodity price assumption is doing a lot of work in any NAV.

Filings consulted · 17

Every document the LLM read for this note. Click any row to open the source.

  1. 2025-11-27Arrow Announces Q3 2025 Interim Results2025-11-27_9259966_arrow-announces-q3-2025-interim-results.md0.90
  2. 2025-08-28Arrow Announces Q2 2025 Interim Results2025-08-28_9076528_arrow-announces-q2-2025-interim-results.md0.77
  3. 2025-05-30Q1 2025 Interim Results And Operational Update2025-05-30_8903856_q1-2025-interim-results-and-operational-update.md0.77
  4. 2024-11-28Q3 2024 Interim Results2024-11-28_8577201_q3-2024-interim-results.md0.58
  5. 2024-06-04Replacement Q1 2024 Interim Results2024-06-04_8240029_replacement-q1-2024-interim-results.md0.58
  6. 2024-05-30Q1 2024 Interim Results2024-05-30_8230104_q1-2024-interim-results.md0.58
  7. 2024-04-292023 Annual Results MD Amp A And Reserves Report2024-04-29_8160694_2023-annual-results-md-amp-a-and-reserves-report.md0.45
  8. 2023-11-29Q3 2023 Interim Results2023-11-29_7908873_q3-2023-interim-results.md0.41
  9. 2023-09-21Result OF Agm2023-09-21_7768529_result-of-agm.md0.14
  10. 2023-08-29Arrow Announces Q2 2023 Interim Results2023-08-29_7721130_arrow-announces-q2-2023-interim-results.md0.41
  11. 2023-05-30Q1 2023 Interim Results2023-05-30_7549114_q1-2023-interim-results.md0.41
  12. 2023-05-022022 Annual Results MD Amp A And Reserves Report2023-05-02_7507455_2022-annual-results-md-amp-a-and-reserves-report.md0.25
  13. 2022-05-18Notice OF Agm2022-05-18_6930920_notice-of-agm.md0.07
  14. 2022-04-262021 Annual Results MD Amp A And Reserves Report2022-04-26_7041716_2021-annual-results-md-amp-a-and-reserves-report.md0.25
  15. 2021-11-25Replacement 3rd Quarter Interim Results2021-11-25_6638970_replacement-3rd-quarter-interim-results.md0.23
  16. 2021-11-24Third Quarter Interim Results2021-11-24_6839306_third-quarter-interim-results.md0.23
  17. 2021-10-29Investor Presentation2021-10-29_6622344_investor-presentation.md0.17

This research note was authored by a large language model after reading 18 regulatory filings published between 2021-10-29 and 2025-11-27. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.